Literature DB >> 20568031

[Position of the German Society of Ophthalmology, the Retinal Society and the German Professional Association of Ophthalmologists on therapy of macular edema in retinal vein occlusion].

.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20568031     DOI: 10.1007/s00347-010-2223-7

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  6 in total

1.  [The value of acetylsalicylic acid in retinal vein occlusion].

Authors:  B Mazinani; N Plange; P Walter
Journal:  Ophthalmologe       Date:  2010-11       Impact factor: 1.059

Review 2.  [Statement of the Professional Association of Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on intravitreal treatment of vision-reducing macular edema by retinal vein occlusion : Treatment strategies, status 24 April 2018].

Authors: 
Journal:  Ophthalmologe       Date:  2018-10       Impact factor: 1.059

Review 3.  [Retinal vascular diseases reflecting generalized vascular alterations. What can be mutually learnt?].

Authors:  N Feltgen; P Franko Zeitz
Journal:  Ophthalmologe       Date:  2014-01       Impact factor: 1.059

4.  [Ophthalmologic diagnostic procedures and imaging of retinal vein occlusions].

Authors:  A Mirshahi; K Lorenz; C Kramann; B Stoffelns; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2011-02       Impact factor: 1.059

5.  [Intravitreal treatment of patients with branch retinal vein occlusion depending on the duration of macular edema].

Authors:  M Rehak; E Spies; M Scholz; P Wiedemann
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

6.  Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion.

Authors:  Kleanthis Manousaridis; Silvia Peter; Stefan Mennel
Journal:  Int Ophthalmol       Date:  2016-04-04       Impact factor: 2.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.